Stay updated on Fremanezumab Subq for Migraine Preven Clinical Trial

Sign up to get notified when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fremanezumab Subq for Migraine Preven Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing all participating sites (US states and Ontario). Removed the individual state location subsections and the per-location links. Revision: v3.3.3.
    Difference
    2%
    Check dated 2025-12-24T14:50:06.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    PubMed publications note updated to indicate automatic population from PubMed and possible non-relevance to the study; revision tag updated to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T14:52:27.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Removal of the site-wide funding/status notice banner; it does not affect the study details, outcomes, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:41:39.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The new screenshot shows non-substantive updates to the page layout and minor copy changes, with core study information remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:27:13.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    2%
    Check dated 2025-10-05T10:24:33.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Summary: The page now announces Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring or narrowing of scope.
    Difference
    0.2%
    Check dated 2025-09-28T03:21:21.000Z thumbnail image

Stay in the know with updates to Fremanezumab Subq for Migraine Preven Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fremanezumab Subq for Migraine Preven Clinical Trial page.